JP2025500918A5 - - Google Patents
Info
- Publication number
- JP2025500918A5 JP2025500918A5 JP2024536126A JP2024536126A JP2025500918A5 JP 2025500918 A5 JP2025500918 A5 JP 2025500918A5 JP 2024536126 A JP2024536126 A JP 2024536126A JP 2024536126 A JP2024536126 A JP 2024536126A JP 2025500918 A5 JP2025500918 A5 JP 2025500918A5
- Authority
- JP
- Japan
- Prior art keywords
- identity
- antigen
- amino acid
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291305P | 2021-12-17 | 2021-12-17 | |
| US63/291,305 | 2021-12-17 | ||
| PCT/US2022/081745 WO2023114965A2 (en) | 2021-12-17 | 2022-12-16 | Antigen binding polypeptide complexes containing extracellular domains of tnfsf ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500918A JP2025500918A (ja) | 2025-01-15 |
| JP2025500918A5 true JP2025500918A5 (enExample) | 2025-12-23 |
Family
ID=86773602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536126A Pending JP2025500918A (ja) | 2021-12-17 | 2022-12-16 | Ｔｎｆｓｆリガンドの細胞外ドメインを含有する抗原結合ポリペプチド複合体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240034808A1 (enExample) |
| EP (1) | EP4448585A4 (enExample) |
| JP (1) | JP2025500918A (enExample) |
| KR (1) | KR20240133797A (enExample) |
| CN (1) | CN118613504A (enExample) |
| AR (1) | AR128013A1 (enExample) |
| AU (1) | AU2022416564A1 (enExample) |
| CA (1) | CA3239979A1 (enExample) |
| CL (1) | CL2024001751A1 (enExample) |
| IL (1) | IL313617A (enExample) |
| MX (1) | MX2024007120A (enExample) |
| TW (1) | TW202330588A (enExample) |
| WO (1) | WO2023114965A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118251411A (zh) * | 2021-09-29 | 2024-06-25 | 摩德斯医疗股份有限公司 | 抗原结合多肽、抗原结合多肽复合物及其使用方法 |
| WO2025096824A1 (en) * | 2023-10-31 | 2025-05-08 | Modex Therapeutics, Inc. | Targeted lnp delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9914761B2 (en) * | 2014-07-10 | 2018-03-13 | Washington University | Oligomers for TNF superfamily inhibition |
| MA41460A (fr) * | 2015-02-03 | 2017-12-12 | Oncomed Pharm Inc | Agents de liaison à la tnfrsf et leurs utilisations |
| WO2018151820A1 (en) * | 2017-02-16 | 2018-08-23 | Elstar Therapeutics, Inc. | Multifunctional molecules comprising a trimeric ligand and uses thereof |
| CN111315405A (zh) * | 2017-11-09 | 2020-06-19 | 免疫医疗有限责任公司 | 双特异性融合多肽及其使用方法 |
| MX2021000307A (es) * | 2018-07-11 | 2021-09-08 | Momenta Pharmaceuticals Inc | Composiciones y métodos relacionados con constructos de dominio de unión a antígeno-fc dirigidos a cd38 diseñados por ingeniería genética. |
| WO2021077132A1 (en) * | 2019-10-14 | 2021-04-22 | The University Of Chicago | Methods and compositions comprising modified fab scaffolds and protein g fab binding domains |
-
2022
- 2022-12-16 IL IL313617A patent/IL313617A/en unknown
- 2022-12-16 KR KR1020247023799A patent/KR20240133797A/ko active Pending
- 2022-12-16 CA CA3239979A patent/CA3239979A1/en active Pending
- 2022-12-16 WO PCT/US2022/081745 patent/WO2023114965A2/en not_active Ceased
- 2022-12-16 AR ARP220103488A patent/AR128013A1/es unknown
- 2022-12-16 JP JP2024536126A patent/JP2025500918A/ja active Pending
- 2022-12-16 MX MX2024007120A patent/MX2024007120A/es unknown
- 2022-12-16 EP EP22908734.1A patent/EP4448585A4/en active Pending
- 2022-12-16 TW TW111148443A patent/TW202330588A/zh unknown
- 2022-12-16 CN CN202280090449.4A patent/CN118613504A/zh active Pending
- 2022-12-16 AU AU2022416564A patent/AU2022416564A1/en active Pending
- 2022-12-16 US US18/067,230 patent/US20240034808A1/en active Pending
-
2024
- 2024-06-13 CL CL2024001751A patent/CL2024001751A1/es unknown